The Use of Biomarkers to Predict CNS Involvement in Diffuse Large B-Cell Lymphoma: a Danish Nationwide Registry Study

CompletedOBSERVATIONAL
Enrollment

2,969

Participants

Timeline

Start Date

January 1, 2014

Primary Completion Date

January 1, 2021

Study Completion Date

January 1, 2021

Conditions
Diffuse Large B Cell LymphomaDiffuse Large B-Cell Lymphoma Cell of OriginDiffuse Large B-cell Lymphoma Recurrent
All Listed Sponsors
collaborator

Zealand University Hospital

OTHER

collaborator

Odense University Hospital

OTHER

collaborator

Aarhus University Hospital

OTHER

collaborator

Vejle Hospital

OTHER

collaborator

Aalborg University Hospital

OTHER

collaborator

Rigshospitalet, Denmark

OTHER

lead

Herlev Hospital

OTHER

NCT05169203 - The Use of Biomarkers to Predict CNS Involvement in Diffuse Large B-Cell Lymphoma: a Danish Nationwide Registry Study | Biotech Hunter | Biotech Hunter